Press office overview
Stem Cell Sciences UK Ltd is a wholly owned subsidiary of StemCells, Inc., a clinical-stage biotechnology company headquartered in Palo Alto, California (USA). StemCells, Inc. is traded on the Nasdaq Global Market under the ticker symbol STEM.
Click here to visit the StemCells, Inc. investor relations website.
For investor relations and media inquiries, please contact:
Megan Meloni
Director, Investor Relations & Corporate Communications
Phone: +1 650 475 3100, ext. 105